drugset / Trial / NCT02115308
Characterization of Changes in Ventricular Mechanics in Response to Lexiscan Stress Using Tagged Cine Cardiac Magnetic Resonance Imaging
Phase 4
Completed
40 enrolled
Timothy M. Bateman
Saint Luke's Cardiovascular Consultants · collabSaint Luke's Health System · collab
NaSingle-groupOpen-labelDiagnostic
Summary
The purpose of this study is to measure the changes in cardiac function during a Lexiscan pharmacologic stress test using cardiac magnetic resonance imaging test.
Timeline
- Start
- 2014-09-03
- Primary completion
- 2018-01-16
- Completion
- 2018-03-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Regadenoson | Diagnostic / imaging agent | 0.4 mg | — |